![Julie Dechanet-Merville](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Julie Dechanet-Merville
Direttore/Membro del Consiglio presso Lymphact - Lymphocyte Activation Technologies SA
Posizioni attive di Julie Dechanet-Merville
Società | Posizione | Inizio | Fine |
---|---|---|---|
Lymphact - Lymphocyte Activation Technologies SA
![]() Lymphact - Lymphocyte Activation Technologies SA BiotechnologyHealth Technology Lymphact - Lymphocyte Activation Technologies SA provides biotechnology solutions. It develops treatments for cancer and chronic viral diseases. The firm offers a technology platform that generates autologous and heterologous cellular immune therapies for clinical applications. The company was founded by Diogo Remechido in 2013 and is headquartered in Lisbon, Portugal. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Julie Dechanet-Merville
Statistiche
Distribuzione geografica
Portogallo | 2 |
Posizioni
Director/Board Member | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Lymphact - Lymphocyte Activation Technologies SA
![]() Lymphact - Lymphocyte Activation Technologies SA BiotechnologyHealth Technology Lymphact - Lymphocyte Activation Technologies SA provides biotechnology solutions. It develops treatments for cancer and chronic viral diseases. The firm offers a technology platform that generates autologous and heterologous cellular immune therapies for clinical applications. The company was founded by Diogo Remechido in 2013 and is headquartered in Lisbon, Portugal. | Health Technology |